Abstracts tagged "Fatigue and rheumatoid arthritis (RA)"

Abstract Number: 1507 • 2018 ACR/ARHP Annual Meeting
Predictors of Fatigue and Persistent Fatigue in Early Rheumatoid Arthritis: A Longitudinal Observational Study
Samantha Rodriguez-Muguruza¹, Bernard Combe², Francis Guillemin³, Bruno Fautrel⁴, Alejandro Olivé-Marqués⁵, Sara Marsal⁶, Oliver Valero⁷, Nathalie Rincheval⁸ and Cédric Lukas⁹, ¹Rheumatology, Hospital Verge de la Cinta, Tarragona, Spain, ²Rheumatology, CHU Montpellier, Montpellier University, Montpellier, France, ³University of Lorraine, Nancy, France, Nancy, France, ⁴University Pierre et Marie Curie, Paris, France, ⁵Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ⁶Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ⁷Servei d’estadística aplicada, Universitat Autonoma de Barcelona, Barcelona, Spain, ⁸EA2415, Montpellier, France, ⁹Rheumatology, Lapeyronie Hospital and EA2415 Montpellier University, Montpellier, France
Background/Purpose: Fatigue is a multifactorial and persistent symptom reported by patients with rheumatoid arthritis (RA). It is considered as frequent as pain. It would be…
Abstract Number: 1552 • 2016 ACR/ARHP Annual Meeting
The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
Anne Tournadre¹, Bruno Pereira², Laure Gossec³, Martin Soubrier⁴ and Maxime Dougados⁵, ¹Rheumatology, UNH-UMR 1019 INRA University of Auvergne and Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, ²Biostatistics unit (DRCI), CHU Gabriel Montpied, Clermont-Ferrand, France, ³Sorbonne Universités, UPMC University Paris 06, Paris, France, Paris, France, ⁴Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, ⁵Paris-Descartes University, Paris, France
Background/Purpose: The mechanisms of fatigue in rheumatoid arthritis (RA) are still unclear and the effect of antirheumatic drugs on fatigue not fully established. Objectives: To…
Abstract Number: 2602 • 2015 ACR/ARHP Annual Meeting
CCP Antibody Negativity Is Associated with Higher Fatigue in Rheumatoid Arthritis
Laura Cappelli¹, Susan J. Bartlett^2,3, Michelle Jones⁴ and Clifton Bingham⁴, ¹Ste 4500, Johns Hopkins University, Baltimore, MD, ²Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, ³Medicine , Divisions of Clinical Epidemiology, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ⁴Johns Hopkins University, Baltimore, MD
Background/Purpose: Fatigue in rheumatoid arthritis (RA) is common and highly debilitating. Emerging evidence suggests that seronegative RA patients differ from their seropositive peers in…
Abstract Number: 3255 • 2015 ACR/ARHP Annual Meeting
Brain White Matter Integrity: A Future Biomarker for Rheumatoid Arthritis Related Fatigue?
Neil Basu¹, Marayam Alsyedalhashem², Mariella D'Allesandro³, Alison D. Murray², Daniel J. Clauw⁴ and Gordon D. Waiter², ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Aberdeen Biomedical Imaging Centre, University of Aberdeen, Aberdeen, United Kingdom, ³Muscloskeletal Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ⁴Anesthesiology, University of Michigan, Ann Arbor, MI
Background/Purpose: Fatigue is a major burden among patients with rheumatoid arthritis (RA). The identification of reliable biomarkers would greatly enhance research in this challenging field. …
Abstract Number: 2811 • 2014 ACR/ARHP Annual Meeting
Improvements in Rheumatoid Arthritis Related Fatigue Are Driven By Reductions in Pain, Not Disease Activity – Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Katie L Druce¹, Gareth T Jones², Gary J. Macfarlane¹ and Neil Basu¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Musculoskeletal Research Collaboration (Epidemiology Group),, University of Aberdeen, Aberdeen, United Kingdom
Background/Purpose: Rheumatoid Arthritis (RA) patients commonly report reductions in fatigue after commencing Anti-TNF therapy. The mechanisms behind such reductions have not been determined, although it…
Abstract Number: 2372 • 2014 ACR/ARHP Annual Meeting
Fatigue and Related Factors in Patients with Rheumatoid Arthritis Treated with Tocilizumab in Daily Clinical Setting
H Corominas¹, C Alegre de Miguel², M Rodríguez-Gómez³, C Marras Fernández-Cid⁴, F Maceiras Pan⁵ and ACT-AXIS Study Group, ¹Rheumatology, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain, ²Rheumatology, Hospital Universitari Vall d'Hebron, Barcelona, Spain, ³Rheumatology, Complejo Hospitalario Cristal Piñor, Ourense, Spain, ⁴Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, ⁵Rheumatology, Complejo Hospitalario Arquitecto Marcide-Profesor Novoa Santos, A Coruña, Spain
Background/Purpose: Fatigue in RA possibly resulting from alterations in the HPA axis like occurs with others RA symptoms as morning stiffness, and mood and sleep…
Abstract Number: 377 • 2014 ACR/ARHP Annual Meeting
Fatigue Fluctuates Substantially over Time in Rheumatoid Arthritis Patients Despite Stable Disease Activity during Treatment with Biological Agents
Emilie Lund Egsmose¹, René Cordtz¹ and Ole Rintek Madsen², ¹Dept. of Rheumatology/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark, ²Dept. of Rheumatoglogy/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark
Background/Purpose Fatigue (FTG) is a symptom commonly reported by patients with rheumatoid arthritis (RA). Little is known about its nature and etiology. The number of…
Abstract Number: 2911 • 2013 ACR/ARHP Annual Meeting
The Challenge To Develop a Multidimensional Computerized Adaptive Test For Fatigue In Rheumatoid Arthritis
Stephanie Nikolaus¹, Christina Bode², Erik Taal³, Cees A.W. Glas⁴ and Mart A.F.J. van de Laar⁵, ¹Behavioral Sciences, University of Twente, Enschede, Netherlands, ²Faculty of Behavioral Sciences, University of Twente, Enschede, Netherlands, ³Psychology, Health and Technology, University of Twente, Enschede, Netherlands, ⁴Research Methodology, Measurement and Data Analysis, University of Twente, Enschede, Netherlands, ⁵Rheumatology, Medisch Spectrum Twente & University of Twente, Enschede, Netherlands
Background/Purpose: Computerized adaptive testing (CAT) provides the possibility to measure patient reported outcomes precisely at individual level. As items are selected based on the previous…
Abstract Number: 2717 • 2013 ACR/ARHP Annual Meeting
Fatigue in Rheumatoid Arthritis Is Associated With Modifiable Lifestyle Factors
Patricia P. Katz¹, Vladimir Chernitskiy² and David I. Daikh², ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: Fatigue has been identified as a major concern for individuals with rheumatoid arthritis (RA) and has been endorsed as a core outcome measure. However,…
Abstract Number: 1292 • 2012 ACR/ARHP Annual Meeting
Fatigue Is an Independent Variable Predicting Physical Function and Disease Activity Score-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab: Results From Phase 3, Placebo Controlled Clinical Trial
Rene Westhovens¹, Michael Weinblatt², Chenglong Han³, Tim Gathany⁴, Lilianne Kim⁵, Michael Mack⁶, Jiandong Lu⁶, Daniel Baker⁷, Alan Mendelsohn⁷ and Clifton O. Bingham III⁸, ¹Rheumatology, University Hospital KU Leuven, Leuven, Belgium, ²Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, ³Outcomes Research, Johnson & Johnson Pharmaceutical Services, LLC, Malvern, PA, ⁴Janssen Global Services, LLC., Malvern, PA, ⁵Janssen Research & Development, a division of Pharmaceutical Research & Development LLC, Janssen Research & Development, LLC, Malvern, PA, ⁶Biostatistics, Janssen Research & Development, LLC., Spring House, PA, ⁷Immunology, Janssen Research & Development, LLC, Spring House, PA, ⁸Department of Medicine, Johns Hopkins University, Baltimore, MD
Background/Purpose: To evaluate the association of fatigue with physical function and disease activity in patients with rheumatoid arthritis (RA), and the impact of treatment with…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].